← Open Payments lookup

ASHLEY HEIMERMAN: Open Payments

NPI 1629620117 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$160 in 8 payments from 6 companies in 2025. Trend: 2023 $71 · 2024 $168 · 2025 $160

Food & beverage: $160
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.2$41
Insulet Corporation2$37
Dexcom, Inc.1$29
Tandem Diabetes Care, Inc.1$18
Xeris Pharmaceuticals, Inc.1$18
ABBVIE INC.1$17

Products named: CRENESSITY, Omnipod, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN, LUPRON DEPOT.

Industry payments across MO — which companies pay providers there.